Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID

IMI CANC-ID Consortium

doi:10.1158/1538-7445.SABCS18-3190

Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID

IMI CANC-ID Consortium

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Number of pages	2
Journal	Cancer Research
Volume	79
Issue number	13
DOIs	https://doi.org/10.1158/1538-7445.SABCS18-3190
Publication status	Published - Jul-2019
Event	Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Atlanta, Gabon Duration: 29-Mar-2019 → 3-Apr-2019

Access to Document

10.1158/1538-7445.SABCS18-3190

Handle.net

Persistent link

Cite this

@article{5b54e6763faf487cbcb9a19ddf57288d,

title = "Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID",

author = "{IMI CANC-ID Consortium} and Klaus Pantel and Terstappen, {Leon W.} and Nicolo Manaresi and Groen, {Harry J.} and Schuuring, {Ed M.} and Ellen Heitzer and Michael Speicher and Bjorn Naume and Kyte, {Jon Amund} and Thomas Schlange",

year = "2019",

month = jul,

doi = "10.1158/1538-7445.SABCS18-3190",

language = "English",

volume = "79",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "AMER ASSOC CANCER RESEARCH",

number = "13",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR) ; Conference date: 29-03-2019 Through 03-04-2019",

}

TY - JOUR

T1 - Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID

AU - IMI CANC-ID Consortium

AU - Pantel, Klaus

AU - Terstappen, Leon W.

AU - Manaresi, Nicolo

AU - Groen, Harry J.

AU - Schuuring, Ed M.

AU - Heitzer, Ellen

AU - Speicher, Michael

AU - Naume, Bjorn

AU - Kyte, Jon Amund

AU - Schlange, Thomas

PY - 2019/7

Y1 - 2019/7

U2 - 10.1158/1538-7445.SABCS18-3190

DO - 10.1158/1538-7445.SABCS18-3190

M3 - Meeting Abstract

SN - 0008-5472

VL - 79

JO - Cancer Research

JF - Cancer Research

IS - 13

T2 - Annual Meeting of the American-Association-for-Cancer-Research (AACR)

Y2 - 29 March 2019 through 3 April 2019

ER -